Risk factors of multidrug-resistant organisms neonatal sepsis in Surabaya tertiary referral hospital: a single-center

Stefani Miranda1, Aminuddin Harahap2, Dominicus Husada3

  • 1Department of Child Health, Faculty of Medicine, Hang Tuah University/dr. Ramelan Navy Central Hospital, Jalan Gadung No. 1, Surabaya, East Java, 60244, Indonesia. stefmir10@gmail.com.

BMC Pediatrics
|February 29, 2024
PubMed
Abstract

Insights

Multidrug-resistant organism neonatal sepsis is a significant threat, with risk factors including low birth weight, prolonged membrane rupture, and meconium-stained fluid. Improving infection control is crucial to combat drug-resistant infections in newborns.

Area of Science:

  • Neonatal Intensive Care Unit (NICU) research
  • Infectious Diseases
  • Public Health

Background:

  • Antimicrobial resistance is a growing global health crisis, particularly concerning in neonatal sepsis.
  • Multidrug-Resistant Organisms (MDROs) contribute to increased morbidity and mortality in neonates.
  • Understanding risk factors for MDRO neonatal sepsis is critical for effective intervention.

Purpose of the Study:

  • To identify significant risk factors associated with the development of Multidrug-Resistant Organism (MDRO) neonatal sepsis.
  • To inform targeted infection control strategies within the Neonatal Intensive Care Unit (NICU).

Main Methods:

  • A cross-sectional study involving 113 neonates diagnosed with sepsis.
  • Blood cultures were analyzed for bacterial growth.
  • Univariate and multivariate logistic regression analyses were employed to determine risk factors.

Main Results:

  • Multidrug-resistant organisms (MDROs) were identified in 80.5% of neonatal sepsis cases.
  • Significant risk factors included lower birth weight, premature rupture of membranes (≥18 hours), and meconium-stained amniotic fluid.
  • Longer hospital stays, lower Apgar scores, and respiratory support (invasive/non-invasive ventilation) were also significant risk factors.

Conclusions:

  • Several key factors increase the risk of developing drug-resistant neonatal sepsis.
  • The findings highlight the urgent need for enhanced infection control measures in NICUs.
  • Addressing these risk factors can help mitigate the burden of antibiotic resistance in neonatal care.

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...